The Private Investment Funds team advised Ampersand Capital Partners on the closing of the firm's latest fund, Ampersand 2020 Limited Partnership ("AMP-20"), with $690 million in limited partner commitments. AMP-20, Ampersand's tenth fund since 1992, was significantly oversubscribed and held a single close three months after launch. With AMP-20, Ampersand plans to continue the firm's strategy of making growth-oriented investments within targeted sectors of the healthcare industry. Ampersand focuses on both majority and minority investments in companies with $10 to $100 million in revenues and positive EBITDA.
Founded in 1988, Ampersand is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience in seeking to build value and drive strong long-term performance alongside its portfolio company management teams.
The Goodwin team was led by James Barrett, Daniel Karelitz, and Brian Fiske.